These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 18851715)

  • 21. Distinctive effects of the cellular inhibitor of apoptosis protein c-IAP2 through stabilization by XIAP in glioblastoma multiforme cells.
    Yang W; Cooke M; Duckett CS; Yang X; Dorsey JF
    Cell Cycle; 2014; 13(6):992-1005. PubMed ID: 24552816
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibitors of apoptosis proteins (IAPs) as potential molecular targets for therapy of hematological malignancies.
    Smolewski P; Robak T
    Curr Mol Med; 2011 Nov; 11(8):633-49. PubMed ID: 21902653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IFN-γ combined with targeting of XIAP leads to increased apoptosis-sensitisation of TRAIL resistant pancreatic carcinoma cells.
    Büneker CK; Yu R; Deedigan L; Mohr A; Zwacka RM
    Cancer Lett; 2012 Mar; 316(2):168-77. PubMed ID: 22104728
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of immune signalling by inhibitors of apoptosis.
    Beug ST; Cheung HH; LaCasse EC; Korneluk RG
    Trends Immunol; 2012 Nov; 33(11):535-45. PubMed ID: 22836014
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Expression patterns of inhibitor of apoptosis proteins in malignant pleural mesothelioma.
    Gordon GJ; Mani M; Mukhopadhyay L; Dong L; Edenfield HR; Glickman JN; Yeap BY; Sugarbaker DJ; Bueno R
    J Pathol; 2007 Mar; 211(4):447-54. PubMed ID: 17253596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessment of IAP (inhibitor of apoptosis) proteins as predictors of response to chemotherapy in advanced non-small-cell lung cancer patients.
    Ferreira CG; van der Valk P; Span SW; Jonker JM; Postmus PE; Kruyt FA; Giaccone G
    Ann Oncol; 2001 Jun; 12(6):799-805. PubMed ID: 11484955
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Targeting inhibitor of apoptosis proteins in combination with dacarbazine or TRAIL in melanoma cells.
    Engesæter BO; Sathermugathevan M; Hellenes T; Engebråten O; Holm R; Flørenes VA; Mælandsmo GM
    Cancer Biol Ther; 2011 Jul; 12(1):47-58. PubMed ID: 21508672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound.
    Cheung HH; Mahoney DJ; Lacasse EC; Korneluk RG
    Cancer Res; 2009 Oct; 69(19):7729-38. PubMed ID: 19773432
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced cytoprotective effects of the inhibitor of apoptosis protein cellular IAP1 through stabilization with TRAF2.
    Csomos RA; Brady GF; Duckett CS
    J Biol Chem; 2009 Jul; 284(31):20531-9. PubMed ID: 19506082
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of XIAP in inhibiting cisplatin-induced caspase activation in non-small cell lung cancer cells: a small molecule Smac mimic sensitizes for chemotherapy-induced apoptosis by enhancing caspase-3 activation.
    Checinska A; Hoogeland BS; Rodriguez JA; Giaccone G; Kruyt FA
    Exp Cell Res; 2007 Apr; 313(6):1215-24. PubMed ID: 17291493
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The X-linked inhibitor of apoptosis protein (XIAP) is involved in melanoma invasion by regulating cell migration and survival.
    Ayachi O; Barlin M; Broxtermann PN; Kashkar H; Mauch C; Zigrino P
    Cell Oncol (Dordr); 2019 Jun; 42(3):319-329. PubMed ID: 30778852
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IAP antagonists induce autoubiquitination of c-IAPs, NF-kappaB activation, and TNFalpha-dependent apoptosis.
    Varfolomeev E; Blankenship JW; Wayson SM; Fedorova AV; Kayagaki N; Garg P; Zobel K; Dynek JN; Elliott LO; Wallweber HJ; Flygare JA; Fairbrother WJ; Deshayes K; Dixit VM; Vucic D
    Cell; 2007 Nov; 131(4):669-81. PubMed ID: 18022362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Design of small-molecule Smac mimetics as IAP antagonists.
    Wang S
    Curr Top Microbiol Immunol; 2011; 348():89-113. PubMed ID: 21072626
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synergy is achieved by complementation with Apo2L/TRAIL and actinomycin D in Apo2L/TRAIL-mediated apoptosis of prostate cancer cells: role of XIAP in resistance.
    Ng CP; Zisman A; Bonavida B
    Prostate; 2002 Dec; 53(4):286-99. PubMed ID: 12430140
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of physiological and synthetic IAP antagonism on c-IAP-dependent signaling.
    Kocab AJ; Veloso A; Paulsen MT; Ljungman M; Duckett CS
    Oncogene; 2015 Oct; 34(43):5472-81. PubMed ID: 25659587
    [TBL] [Abstract][Full Text] [Related]  

  • 36. X-linked inhibitor regulating TRAIL-induced apoptosis in chemoresistant human primary glioblastoma cells.
    Roa WH; Chen H; Fulton D; Gulavita S; Shaw A; Th'ng J; Farr-Jones M; Moore R; Petruk K
    Clin Invest Med; 2003 Oct; 26(5):231-42. PubMed ID: 14596484
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel role for inhibitor of apoptosis (IAP) proteins as regulators of endothelial barrier function by mediating RhoA activation.
    Hornburger MC; Mayer BA; Leonhardt S; Willer EA; Zahler S; Beyerle A; Rajalingam K; Vollmar AM; Fürst R
    FASEB J; 2014 Apr; 28(4):1938-46. PubMed ID: 24371121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting inhibitor of apoptosis proteins (IAPs) enhances susceptibility of oral squamous carcinoma cells to cisplatin.
    Gao T; Magnano S; Rynne A; O'Kane L; Barroeta PH; Zisterer DM
    Exp Cell Res; 2024 Apr; 437(1):113995. PubMed ID: 38490621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sensitization of human bladder tumor cells to TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis with a small molecule IAP antagonist.
    Griffith TS; Kucaba TA; O'Donnell MA; Burns J; Benetatos C; McKinlay MA; Condon S; Chunduru S
    Apoptosis; 2011 Jan; 16(1):13-26. PubMed ID: 20734142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent advances in understanding inhibitor of apoptosis proteins.
    Lalaoui N; Vaux DL
    F1000Res; 2018; 7():. PubMed ID: 30631429
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.